These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 20735991)
1. Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16:0-ceramide. Schiffmann S; Ziebell S; Sandner J; Birod K; Deckmann K; Hartmann D; Rode S; Schmidt H; Angioni C; Geisslinger G; Grösch S Biochem Pharmacol; 2010 Dec; 80(11):1632-40. PubMed ID: 20735991 [TBL] [Abstract][Full Text] [Related]
2. The equilibrium between long and very long chain ceramides is important for the fate of the cell and can be influenced by co-expression of CerS. Hartmann D; Wegner MS; Wanger RA; Ferreirós N; Schreiber Y; Lucks J; Schiffmann S; Geisslinger G; Grösch S Int J Biochem Cell Biol; 2013 Jul; 45(7):1195-203. PubMed ID: 23538298 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Cui W; Yu CH; Hu KQ Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255 [TBL] [Abstract][Full Text] [Related]
4. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner. Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235 [TBL] [Abstract][Full Text] [Related]
5. Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner. Fekry B; Esmaeilniakooshkghazi A; Krupenko SA; Krupenko NI PLoS One; 2016; 11(1):e0146618. PubMed ID: 26783755 [TBL] [Abstract][Full Text] [Related]
6. Ceramide synthase 6 plays a critical role in the development of experimental autoimmune encephalomyelitis. Schiffmann S; Ferreiros N; Birod K; Eberle M; Schreiber Y; Pfeilschifter W; Ziemann U; Pierre S; Scholich K; Grösch S; Geisslinger G J Immunol; 2012 Jun; 188(11):5723-33. PubMed ID: 22544924 [TBL] [Abstract][Full Text] [Related]
7. Inhibitors of specific ceramide synthases. Schiffmann S; Hartmann D; Fuchs S; Birod K; Ferreiròs N; Schreiber Y; Zivkovic A; Geisslinger G; Grösch S; Stark H Biochimie; 2012 Feb; 94(2):558-65. PubMed ID: 21945810 [TBL] [Abstract][Full Text] [Related]
8. The anti-proliferative potency of celecoxib is not a class effect of coxibs. Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer. Wang L; Chen W; Xie X; He Y; Bai X Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340 [TBL] [Abstract][Full Text] [Related]
10. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455 [TBL] [Abstract][Full Text] [Related]
11. Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia. Verlekar D; Wei SJ; Cho H; Yang S; Kang MH Cell Death Dis; 2018 Sep; 9(9):925. PubMed ID: 30206207 [TBL] [Abstract][Full Text] [Related]
12. Ceramide synthases and ceramide levels are increased in breast cancer tissue. Schiffmann S; Sandner J; Birod K; Wobst I; Angioni C; Ruckhäberle E; Kaufmann M; Ackermann H; Lötsch J; Schmidt H; Geisslinger G; Grösch S Carcinogenesis; 2009 May; 30(5):745-52. PubMed ID: 19279183 [TBL] [Abstract][Full Text] [Related]
13. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [TBL] [Abstract][Full Text] [Related]
14. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels. Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415 [TBL] [Abstract][Full Text] [Related]
15. D,L-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (DL-PDMP) increases endoplasmic reticulum stress, autophagy and apoptosis accompanying ceramide accumulation via ceramide synthase 5 protein expression in A549 cells. Yamane M; Miyazawa K; Moriya S; Abe A; Yamane S Biochimie; 2011 Sep; 93(9):1446-59. PubMed ID: 21571032 [TBL] [Abstract][Full Text] [Related]
16. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens. Swamy MV; Cooma I; Reddy BS; Rao CV Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121 [TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 (COX-2)-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. Maier TJ; Schilling K; Schmidt R; Geisslinger G; Grösch S Biochem Pharmacol; 2004 Apr; 67(8):1469-78. PubMed ID: 15041464 [TBL] [Abstract][Full Text] [Related]
19. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism. Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026 [TBL] [Abstract][Full Text] [Related]
20. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach. Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]